Neurogene Inc.
SEC CIK 1404644 · NLTX · last insider filing 2026-06-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Woods Keith | Director | filed 2026–2026 |
| Cvijic Christine Mikail | Director · President and CFO | filed 2023–2026 |
| Mcminn Rachel | Director · Chief Executive Officer | filed 2023–2026 |
| Baffi Robert | Director | filed 2023–2026 |
| Palekar Rohan | Director | filed 2022–2026 |
| Noonberg Sarah B. | Director | filed 2019–2026 |
| Freedland Cory S. | Director | filed 2023–2026 |
| Woods Robert Keith | Director | filed 2023–2025 |
| Baker Julian | Director | filed 2015–2023 |
| Baker Felix | Director | filed 2015–2023 |
| Baker Bros. Advisors LP | Director | filed 2015–2023 |
| Baker Brothers Life Sciences LP | Director | filed 2015–2023 |
| 667, L.P. | Director | filed 2015–2023 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2015–2023 |
| Simpson Todd E | Director | filed 2014–2023 |
| Babler Martin | Director | filed 2020–2023 |
| Lavelle Erin | Director | filed 2022–2023 |
| Drachman Jonathan G | Director · See Remarks | filed 2019–2022 |
| Williams Lewis T | Director | filed 2019–2021 |
| Lavelle Erin M. | Director | filed 2020–2021 |
| Nolan Sean P. | Director | filed 2015–2020 |
| Boyd Meta Cantey | Director | filed 2019–2019 |
| Main David | Director · President and CEO | filed 2014–2018 |
| Levitt Daniel J | Director | filed 2014–2018 |
| Pelzer Robert | Director | filed 2014–2018 |
| Bridger Gary | Director | filed 2014–2018 |
| Levy Richard S | Director | filed 2017–2017 |
| Neu Kelvin | Director | filed 2017–2017 |
| Jones Elaine V | Director | filed 2014–2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shafer Christina | Chief Commercial Officer | filed 2026–2026 |
| Jordan Julie | Chief Medical Officer | filed 2024–2026 |
| Cobb Stuart | Chief Scientific Officer | filed 2023–2026 |
| Smith Sean Michael | Principal Accounting Officer | filed 2022–2023 |
| Patel Priti | Chief Medical Officer | filed 2021–2023 |
| Walkey Carl | Senior Vice President | filed 2021–2022 |
| Cochener Donna | General Counsel, SVP Legal | filed 2022–2022 |
| Ho Robert | Chief Financial Officer | filed 2020–2022 |
| Vance Holly | General Counsel | filed 2020–2021 |
| Alam Kamran | CFO, Vice President Finance | filed 2014–2018 |
| Mackenzie Lloyd | VP Technical Operations | filed 2014–2018 |
| Mccloskey Shelley | VP, HR and Administration | filed 2015–2018 |
| Troupin Barbara | Chief Medical Officer | filed 2016–2018 |
| Jenkins Abigail | Chief Commercial Officer | filed 2016–2018 |
| Mitchell David Chilton | VP Global Regulatory & Quality | filed 2014–2017 |
| Shrewsbury Stephen B | CMO; Senior VP Clinical Dev. | filed 2014–2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.